礼来吧
排序:
评论时间
  • 评论时间
  • 发帖时间
阅读评论标题 作者 最后更新
2 0 公告 Notification filed by national security exchange t 礼来资讯 06-02 21:22
2 0 公告 Report of proposed sale of securities 礼来资讯 05-29 03:08
2 0 公告 Report of proposed sale of securities 礼来资讯 05-23 02:07
2 0 公告 Current report, items 8.01 and 9.01 礼来资讯 05-21 04:40
2 0 公告 Report of proposed sale of securities 礼来资讯 05-21 04:26
2 0 公告 Statement of changes in beneficial ownership of se 礼来资讯 05-20 04:24
2 0 公告 Statement of changes in beneficial ownership of se 礼来资讯 05-20 04:23
2 0 公告 Statement of changes in beneficial ownership of se 礼来资讯 05-20 04:22
2 0 公告 Statement of changes in beneficial ownership of se 礼来资讯 05-20 04:21
2 0 公告 Specialized disclosure report 礼来资讯 05-12 04:36
2 0 公告 Prospectus [Rule 424(b)(2)] 礼来资讯 05-08 18:16
2 0 公告 Current report, item 5.07 礼来资讯 05-08 05:06
2 0 公告 Statement of changes in beneficial ownership of se 礼来资讯 05-08 04:41
2 0 研报 GLP-1市占率保持强劲,Foundayo开启商业化 礼来资讯 05-07 12:06
2 0 公告 Filing under Securities Act Rules 163/43 礼来资讯 05-07 05:30
2 0 公告 Report of proposed sale of securities 礼来资讯 05-07 04:42
2 0 公告 Prospectus [Rule 424(b)(2)] 礼来资讯 05-06 20:17
3 0 公告 Statement of Beneficial Ownership by Cer 礼来资讯 05-02 00:53
3 0 公告 Quarterly report [Sections 13 or 15(d)] 礼来资讯 04-30 23:37
3 0 公告 Current report, items 2.02 and 9.01 礼来资讯 04-30 19:08
3 0 公告 Notice of exempt solicitation submitted 礼来资讯 04-30 01:56
1 0 公告 Q1 2026 Lilly Presentation 礼来资讯 04-30 00:00
2 0 公告 Statement of changes in beneficial owner 礼来资讯 04-22 05:07
3 0 公告 Statement of changes in beneficial owner 礼来资讯 04-22 04:33
3 0 公告 Statement of changes in beneficial owner 礼来资讯 04-22 04:32
3 0 公告 Statement of changes in beneficial owner 礼来资讯 04-22 04:30
3 0 公告 [Amend] Statement of Beneficial Ownershi 礼来资讯 04-21 03:28
4 0 公告 Additional definitive proxy soliciting m 礼来资讯 03-31 20:24
4 0 公告 [Amend] Statement of Beneficial Ownershi 礼来资讯 03-27 06:06
5 0 公告 Other definitive proxy statements 礼来资讯 03-21 04:29
6 0 公告 Additional definitive proxy soliciting m 礼来资讯 03-21 04:29
5 0 公告 Statement of changes in beneficial owner 礼来资讯 03-18 04:59
5 0 公告 Statement of changes in beneficial owner 礼来资讯 03-18 04:42
5 0 公告 Statement of changes in beneficial owner 礼来资讯 03-18 04:39
5 0 公告 Statement of changes in beneficial owner 礼来资讯 03-18 04:34
5 0 公告 Other preliminary proxy statements 礼来资讯 03-07 05:43
7 0 公告 Statement of changes in beneficial owner 礼来资讯 02-20 05:21
7 0 公告 Statement of changes in beneficial owner 礼来资讯 02-19 05:32
7 0 公告 Statement of changes in beneficial owner 礼来资讯 02-19 05:31
7 0 公告 Statement of changes in beneficial owner 礼来资讯 02-19 05:31
7 0 公告 Statement of changes in beneficial owner 礼来资讯 02-19 05:29
8 0 公告 Statement of changes in beneficial owner 礼来资讯 02-19 05:29
7 0 公告 Statement of changes in beneficial owner 礼来资讯 02-19 05:28
7 0 公告 Statement of changes in beneficial owner 礼来资讯 02-19 05:25
7 0 公告 Statement of changes in beneficial owner 礼来资讯 02-19 05:23
7 0 资讯 礼来携手清华大学启动阿尔茨海默病科普创意 礼来资讯 02-13 15:42
7 0 资讯 替尔泊肽单药治疗适应症获批,支持中国2型 礼来资讯 02-13 11:20
8 0 资讯 礼来收购Ventyx Biosciences获美国联邦贸易 礼来资讯 02-13 08:41
7 0 公告 [Amend] Statement of changes in benefici 礼来资讯 02-13 05:26
6 0 资讯 礼来公司预计至2026年7月1日 美国医疗保险 礼来资讯 02-13 03:24
7 0 公告 Annual report [Section 13 and 15(d), not 礼来资讯 02-13 03:04
7 0 资讯 替尔泊肽单药治疗适应症获批 推动2型糖尿病 礼来资讯 02-12 15:19
7 0 资讯 礼来替尔泊肽获批单药治疗二型糖尿病 礼来资讯 02-12 14:12
10 0 资讯 “药王”更迭 替尔泊肽年销售额超365亿美元 诺和诺德资讯 02-12 12:54
7 0 资讯 礼来替尔泊肽在华获批单药降糖,去年全球销 礼来资讯 02-12 11:22
7 0 资讯 礼来替尔泊肽获批单药治疗成人2型糖尿病 礼来资讯 02-12 09:52
7 0 公告 Statement of changes in beneficial owner 礼来资讯 02-12 05:31
7 0 公告 Statement of changes in beneficial owner 礼来资讯 02-12 05:29
7 0 公告 Statement of changes in beneficial owner 礼来资讯 02-12 05:28
6 0 公告 Statement of changes in beneficial owner 礼来资讯 02-12 05:28
7 0 公告 Statement of changes in beneficial owner 礼来资讯 02-12 05:26
7 0 公告 Statement of changes in beneficial owner 礼来资讯 02-12 05:25
7 0 公告 Statement of changes in beneficial owner 礼来资讯 02-12 05:23
6 0 公告 Statement of changes in beneficial owner 礼来资讯 02-12 05:23
7 0 公告 Statement of changes in beneficial owner 礼来资讯 02-12 05:21
7 0 公告 Statement of changes in beneficial owner 礼来资讯 02-12 05:21
6 0 公告 Statement of changes in beneficial owner 礼来资讯 02-12 05:20
7 0 公告 Statement of changes in beneficial owner 礼来资讯 02-12 05:18
7 0 公告 Statement of changes in beneficial owner 礼来资讯 02-12 05:16
7 0 资讯 双适应症获批 礼来IL-23p19抑制剂登陆中国 礼来资讯 02-11 17:14
7 0 资讯 礼来这一创新疗法在华获批双适应证,惠及更 礼来资讯 02-11 15:17
7 0 资讯 礼来安妥来利和安妥来在华获批 礼来资讯 02-11 12:44
7 0 资讯 礼来安妥来利和安妥来在华获批 礼来资讯 02-11 12:23
7 0 资讯 礼来安妥来利和安妥来在华获批 礼来资讯 02-11 12:21
12 0 资讯 分子还没成熟、合作已先落地:信达生物与礼 信达生物资讯 02-10 22:56
7 0 研报 替尔泊肽登顶“药王”,Orforglipron即将收 礼来资讯 02-10 17:20
8 0 资讯 深夜!减肥药巨头大涨! 诺和诺德资讯 02-09 23:48
8 0 资讯 信达生物与礼来就创新药研发达成战略合作 信达生物资讯 02-09 07:19
10 0 资讯 信达生物与礼来制药达成战略合作推进肿瘤及 信达生物资讯 02-09 01:34
8 0 资讯 88.5亿美元!千亿创新药巨头又有大动作 信达生物资讯 02-08 23:00
发表新主题
悬赏提问
帖子不见了!怎么办?   
   请登录 登录 | 5秒注册 作者: 退出 
温馨提示: 1.根据《证券法》规定,禁止编造、传播虚假信息或者误导性信息,扰乱证券市场;2.用户在本社区发表的所有资料、言论等仅代表个人观点,与本网站立场无关,不对您构成任何投资建议。用户应基于自己的独立判断,自行决定证券投资并承担相应风险。《东方财富社区管理规定》

扫一扫下载APP

扫一扫下载APP
信息网络传播视听节目许可证:0908328号 经营证券期货业务许可证编号:913101046312860336 违法和不良信息举报:021-61278686 举报邮箱:jubao@eastmoney.com
沪ICP证:沪B2-20070217 网站备案号:沪ICP备05006054号-11 沪公网安备 31010402000120号 版权所有:东方财富网 意见与建议:4000300059/952500